Modified proteins and peptides
The present disclosure relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g., fusions...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Ashman, Claire Morley, Peter Lewis, Alan Peter Birchler, Mary Holland, Claire Sandal, Thomas Steward, Michael De Wildt, Rudolf M. T |
description | The present disclosure relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g., fusions and conjugates) comprise proteins, peptides, antigen binding molecules, antibodies or antibody fragments such as single variable domains. The disclosure further relates to uses and formulations of compositions comprising such modified C-terminally extended and/or amino acid substituted molecules and also to methods of production and expression of these. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US10808040B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US10808040B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US10808040B23</originalsourceid><addsrcrecordid>eNrjZJDzzU_JTMtMTVEoKMovSc3MK1ZIzANyUgtKMlNSi3kYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGBBRCaGDgZGROjBgABXCSp</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Modified proteins and peptides</title><source>esp@cenet</source><creator>Ashman, Claire ; Morley, Peter ; Lewis, Alan Peter ; Birchler, Mary ; Holland, Claire ; Sandal, Thomas ; Steward, Michael ; De Wildt, Rudolf M. T</creator><creatorcontrib>Ashman, Claire ; Morley, Peter ; Lewis, Alan Peter ; Birchler, Mary ; Holland, Claire ; Sandal, Thomas ; Steward, Michael ; De Wildt, Rudolf M. T</creatorcontrib><description>The present disclosure relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g., fusions and conjugates) comprise proteins, peptides, antigen binding molecules, antibodies or antibody fragments such as single variable domains. The disclosure further relates to uses and formulations of compositions comprising such modified C-terminally extended and/or amino acid substituted molecules and also to methods of production and expression of these.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201020&DB=EPODOC&CC=US&NR=10808040B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201020&DB=EPODOC&CC=US&NR=10808040B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ashman, Claire</creatorcontrib><creatorcontrib>Morley, Peter</creatorcontrib><creatorcontrib>Lewis, Alan Peter</creatorcontrib><creatorcontrib>Birchler, Mary</creatorcontrib><creatorcontrib>Holland, Claire</creatorcontrib><creatorcontrib>Sandal, Thomas</creatorcontrib><creatorcontrib>Steward, Michael</creatorcontrib><creatorcontrib>De Wildt, Rudolf M. T</creatorcontrib><title>Modified proteins and peptides</title><description>The present disclosure relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g., fusions and conjugates) comprise proteins, peptides, antigen binding molecules, antibodies or antibody fragments such as single variable domains. The disclosure further relates to uses and formulations of compositions comprising such modified C-terminally extended and/or amino acid substituted molecules and also to methods of production and expression of these.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDzzU_JTMtMTVEoKMovSc3MK1ZIzANyUgtKMlNSi3kYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGBBRCaGDgZGROjBgABXCSp</recordid><startdate>20201020</startdate><enddate>20201020</enddate><creator>Ashman, Claire</creator><creator>Morley, Peter</creator><creator>Lewis, Alan Peter</creator><creator>Birchler, Mary</creator><creator>Holland, Claire</creator><creator>Sandal, Thomas</creator><creator>Steward, Michael</creator><creator>De Wildt, Rudolf M. T</creator><scope>EVB</scope></search><sort><creationdate>20201020</creationdate><title>Modified proteins and peptides</title><author>Ashman, Claire ; Morley, Peter ; Lewis, Alan Peter ; Birchler, Mary ; Holland, Claire ; Sandal, Thomas ; Steward, Michael ; De Wildt, Rudolf M. T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US10808040B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Ashman, Claire</creatorcontrib><creatorcontrib>Morley, Peter</creatorcontrib><creatorcontrib>Lewis, Alan Peter</creatorcontrib><creatorcontrib>Birchler, Mary</creatorcontrib><creatorcontrib>Holland, Claire</creatorcontrib><creatorcontrib>Sandal, Thomas</creatorcontrib><creatorcontrib>Steward, Michael</creatorcontrib><creatorcontrib>De Wildt, Rudolf M. T</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ashman, Claire</au><au>Morley, Peter</au><au>Lewis, Alan Peter</au><au>Birchler, Mary</au><au>Holland, Claire</au><au>Sandal, Thomas</au><au>Steward, Michael</au><au>De Wildt, Rudolf M. T</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Modified proteins and peptides</title><date>2020-10-20</date><risdate>2020</risdate><abstract>The present disclosure relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g., fusions and conjugates) comprise proteins, peptides, antigen binding molecules, antibodies or antibody fragments such as single variable domains. The disclosure further relates to uses and formulations of compositions comprising such modified C-terminally extended and/or amino acid substituted molecules and also to methods of production and expression of these.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US10808040B2 |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Modified proteins and peptides |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T18%3A17%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Ashman,%20Claire&rft.date=2020-10-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS10808040B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |